Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE3.6800
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots3.6000/ 2
- Ask / Lots4.0000/ 7
- Open / Previous Close--- / 3.6800
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 2683 | 3.7 |
| 09:34 ET | 5762 | 3.69 |
| 09:36 ET | 1648 | 3.73 |
| 09:38 ET | 10924 | 3.74 |
| 09:39 ET | 406 | 3.74 |
| 09:41 ET | 700 | 3.725 |
| 09:43 ET | 524 | 3.74 |
| 09:45 ET | 1515 | 3.74 |
| 09:48 ET | 450 | 3.75 |
| 09:50 ET | 3171 | 3.7699 |
| 09:52 ET | 1301 | 3.77 |
| 09:54 ET | 4000 | 3.765 |
| 09:56 ET | 7869 | 3.765 |
| 09:57 ET | 13574 | 3.77 |
| 09:59 ET | 900 | 3.78 |
| 10:01 ET | 1640 | 3.77 |
| 10:03 ET | 2492 | 3.75 |
| 10:06 ET | 1687 | 3.746517 |
| 10:08 ET | 1500 | 3.76 |
| 10:10 ET | 200 | 3.76 |
| 10:12 ET | 800 | 3.755 |
| 10:14 ET | 200 | 3.755 |
| 10:15 ET | 2016 | 3.765 |
| 10:17 ET | 300 | 3.76 |
| 10:19 ET | 400 | 3.74 |
| 10:21 ET | 600 | 3.735 |
| 10:24 ET | 2523 | 3.73 |
| 10:26 ET | 1179 | 3.741 |
| 10:28 ET | 17934 | 3.76 |
| 10:30 ET | 4560 | 3.7514 |
| 10:32 ET | 761 | 3.76 |
| 10:33 ET | 1682 | 3.7512 |
| 10:35 ET | 1418 | 3.76 |
| 10:37 ET | 1650 | 3.76 |
| 10:39 ET | 1615 | 3.745 |
| 10:42 ET | 3850 | 3.75 |
| 10:44 ET | 775 | 3.76 |
| 10:48 ET | 617 | 3.76 |
| 10:50 ET | 200 | 3.755 |
| 10:51 ET | 400 | 3.75 |
| 10:53 ET | 700 | 3.72 |
| 10:55 ET | 100 | 3.705 |
| 10:57 ET | 600 | 3.7 |
| 11:00 ET | 200 | 3.68 |
| 11:02 ET | 200 | 3.685 |
| 11:04 ET | 1164 | 3.695 |
| 11:06 ET | 1421 | 3.705 |
| 11:08 ET | 845 | 3.7 |
| 11:09 ET | 140 | 3.69 |
| 11:11 ET | 1052 | 3.685 |
| 11:13 ET | 100 | 3.69 |
| 11:15 ET | 300 | 3.69 |
| 11:18 ET | 1000 | 3.7 |
| 11:20 ET | 100 | 3.7 |
| 11:22 ET | 4100 | 3.7 |
| 11:24 ET | 200 | 3.69 |
| 11:26 ET | 100 | 3.695 |
| 11:27 ET | 1091 | 3.67 |
| 11:29 ET | 200 | 3.6799 |
| 11:31 ET | 100 | 3.675 |
| 11:33 ET | 1040 | 3.66 |
| 11:36 ET | 3093 | 3.66 |
| 11:40 ET | 500 | 3.64 |
| 11:42 ET | 580 | 3.6398 |
| 11:44 ET | 1300 | 3.6301 |
| 11:45 ET | 2786 | 3.635 |
| 11:47 ET | 1400 | 3.61 |
| 11:49 ET | 14352 | 3.61 |
| 11:51 ET | 1152 | 3.63 |
| 11:54 ET | 460 | 3.6101 |
| 11:56 ET | 568 | 3.6188 |
| 11:58 ET | 824 | 3.625 |
| 12:00 ET | 2000 | 3.63 |
| 12:02 ET | 3655 | 3.625 |
| 12:03 ET | 814 | 3.625 |
| 12:05 ET | 700 | 3.615 |
| 12:07 ET | 200 | 3.605 |
| 12:09 ET | 3294 | 3.6285 |
| 12:14 ET | 550 | 3.62 |
| 12:16 ET | 364 | 3.61 |
| 12:18 ET | 3164 | 3.6152 |
| 12:20 ET | 1212 | 3.62 |
| 12:21 ET | 968 | 3.617 |
| 12:23 ET | 776 | 3.62 |
| 12:25 ET | 400 | 3.62 |
| 12:27 ET | 200 | 3.62 |
| 12:30 ET | 1100 | 3.63 |
| 12:32 ET | 203 | 3.63 |
| 12:34 ET | 1300 | 3.63 |
| 12:39 ET | 923 | 3.61 |
| 12:41 ET | 751 | 3.605 |
| 12:43 ET | 400 | 3.61 |
| 12:45 ET | 2094 | 3.625 |
| 12:48 ET | 1360 | 3.64 |
| 12:50 ET | 1400 | 3.63 |
| 12:52 ET | 100 | 3.635 |
| 12:54 ET | 1100 | 3.64 |
| 12:56 ET | 400 | 3.64 |
| 01:01 ET | 1050 | 3.6388 |
| 01:03 ET | 100 | 3.63 |
| 01:06 ET | 103 | 3.635 |
| 01:08 ET | 100 | 3.64 |
| 01:10 ET | 2340 | 3.66 |
| 01:12 ET | 451 | 3.655 |
| 01:14 ET | 6532 | 3.645 |
| 01:17 ET | 1521 | 3.635 |
| 01:19 ET | 1562 | 3.62 |
| 01:21 ET | 100 | 3.63 |
| 01:24 ET | 1511 | 3.63 |
| 01:26 ET | 930 | 3.64 |
| 01:28 ET | 2500 | 3.655 |
| 01:30 ET | 2500 | 3.6499 |
| 01:32 ET | 1243 | 3.64 |
| 01:33 ET | 3590 | 3.65 |
| 01:35 ET | 1718 | 3.655 |
| 01:37 ET | 800 | 3.655 |
| 01:39 ET | 3513 | 3.67 |
| 01:42 ET | 647 | 3.68 |
| 01:44 ET | 100 | 3.68 |
| 01:48 ET | 2617 | 3.675 |
| 01:50 ET | 1843 | 3.675 |
| 01:51 ET | 100 | 3.675 |
| 01:53 ET | 3295 | 3.685 |
| 01:55 ET | 1950 | 3.68 |
| 01:57 ET | 5908 | 3.675 |
| 02:00 ET | 1409 | 3.68 |
| 02:02 ET | 250 | 3.69 |
| 02:04 ET | 7232 | 3.675 |
| 02:06 ET | 1294 | 3.675 |
| 02:08 ET | 13080 | 3.65 |
| 02:09 ET | 1000 | 3.63 |
| 02:11 ET | 905 | 3.63 |
| 02:13 ET | 3599 | 3.625 |
| 02:15 ET | 4523 | 3.63 |
| 02:18 ET | 100 | 3.63 |
| 02:20 ET | 825 | 3.63 |
| 02:22 ET | 3873 | 3.63 |
| 02:24 ET | 2290 | 3.625 |
| 02:26 ET | 4992 | 3.625 |
| 02:27 ET | 1300 | 3.6201 |
| 02:29 ET | 4871 | 3.62 |
| 02:31 ET | 937 | 3.625 |
| 02:33 ET | 2239 | 3.6291 |
| 02:36 ET | 2218 | 3.63 |
| 02:38 ET | 2343 | 3.635 |
| 02:40 ET | 516 | 3.645 |
| 02:42 ET | 726 | 3.65 |
| 02:44 ET | 200 | 3.6598 |
| 02:45 ET | 500 | 3.655 |
| 02:47 ET | 941 | 3.67 |
| 02:49 ET | 867 | 3.665 |
| 02:51 ET | 600 | 3.67 |
| 02:54 ET | 4501 | 3.645 |
| 02:56 ET | 1655 | 3.655 |
| 02:58 ET | 200 | 3.66 |
| 03:00 ET | 5056 | 3.655 |
| 03:02 ET | 5038 | 3.67 |
| 03:03 ET | 854 | 3.665 |
| 03:05 ET | 5253 | 3.67 |
| 03:07 ET | 1394 | 3.67 |
| 03:09 ET | 2515 | 3.67 |
| 03:12 ET | 1700 | 3.665 |
| 03:14 ET | 3811 | 3.665 |
| 03:16 ET | 2605 | 3.67 |
| 03:18 ET | 1819 | 3.67 |
| 03:20 ET | 1700 | 3.68 |
| 03:21 ET | 2461 | 3.69 |
| 03:23 ET | 5400 | 3.685 |
| 03:25 ET | 9650 | 3.6888 |
| 03:27 ET | 6829 | 3.7 |
| 03:30 ET | 12184 | 3.691 |
| 03:32 ET | 3322 | 3.685 |
| 03:34 ET | 3857 | 3.6999 |
| 03:36 ET | 1181 | 3.7 |
| 03:38 ET | 1717 | 3.695 |
| 03:39 ET | 700 | 3.695 |
| 03:41 ET | 7821 | 3.685 |
| 03:43 ET | 5412 | 3.685 |
| 03:45 ET | 2552 | 3.685 |
| 03:48 ET | 10874 | 3.63 |
| 03:50 ET | 6646 | 3.65 |
| 03:52 ET | 6668 | 3.645 |
| 03:54 ET | 8187 | 3.65 |
| 03:56 ET | 10927 | 3.655 |
| 03:57 ET | 8339 | 3.665 |
| 03:59 ET | 125813 | 3.68 |
Sep 16, 2024
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 9:38PM ET on Monday Sep 16, 2024 by Dow Jones
9:38PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by Oppenheimer, from 2:03PM ET on Monday Sep 16, 2024 by Dow Jones
2:03PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies, from 7:37AM ET on Monday Sep 16, 2024 by Dow Jones
7:37AM ET on Monday Sep 16, 2024 by Dow JonesZentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies, from 7:00AM ET on Monday Sep 16, 2024 by Dow Jones
7:00AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 9, 2024
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 261.7M | -1.3x | --- |
Zura Bio Ltd | 258.9M | -8.2x | --- |
Rezolute Inc | 268.5M | -3.7x | --- |
ESSA Pharma Inc | 268.9M | -9.7x | --- |
Solid Biosciences Inc | 269.0M | -2.1x | --- |
Compass Therapeutics Inc. | 253.2M | -5.1x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Interim Chief Financial Officer, Interim Treasurer, Executive Director
- Cam Gallagher
- President, Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Scientific Officer
- Mark Lackner,
- Chief Medical Officer
- Diana Hausman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $261.7M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.70 |
EPS | $-2.75 |
Book Value | $6.18 |
P/E Ratio | -1.3x |
Price/Sales (TTM) | 6.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -543.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
